Novartis Access programme

Novartis
Novartis Access is a new company-wide business model that supports access to medicine in low- and lower-middle income countries.
Continue reading
Community-based Hypertension Improvement Project

Community-based Hypertension Improvement Project

Novartis
The Community-based Hypertension Improvement Project (ComHIP) is testing an innovative healthcare model for hypertension in Ghana.
Continue reading

Approach to R&D capacity building

Novartis
Novartis takes a comprehensive approach to targeting local R&D capacity building needs.
Continue reading
SMS For Life

SMS for Life

Novartis
Novartis’ SMS for Life programme uses mobile technology to reduce medicine stock-outs in sub-Saharan Africa.
Continue reading

Malaria-focused capacity building

Novartis
Novartis is undertaking several capacity building projects focused on malaria in sub-Saharan Africa.
Continue reading

Financial, Environmental and Social Profit and Loss capturing approach

Novartis
The Financial, Environmental and Social Profit and Loss (FES P&L) approach aims to measure the social and economic impact of Novartis’ social activities on local communities.
Continue reading
Leprosy-focused Capacity Building

Leprosy-focused capacity building

Novartis
Novartis is undertaking a range of projects to build local capacity to address leprosy, mainly in south-east Asia.
Continue reading

Commitment to R&D for AMR

AstraZeneca, GSK, Johnson & Johnson, Merck & Co, Merck KGaA, Novartis, Pfizer, Roche, Sanofi
Nine companies have committed to R&D for antimicrobial resistance (AMR), signing the Davos Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance.
Continue reading

Novartis Access Strategy Framework

Novartis
The Novartis Access Strategy Framework guides the systematic and collaborative development of equitable and affordable access-solutions targeted to serve all segments of the socioeconomic pyramid.
Continue reading

Considering multiple local needs to facilitate rational use of products

Novartis
Novartis adapts brochures and packaging in multiple ways to facilitate rational use of products.
Continue reading